Sequential Afatinib (Afa) And Osimertinib (Osi) In Patients (Pts) With Advanced Egfr Mutation-Positive (Egfrm Plus ) Nsclc Who Acquire The T790m Resistance Mutation: A Non-Interventional Cohort Study (Upswing)
ANNALS OF ONCOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要